Some people refer to them as S$ma or T! As part of my reporting for this story, I joined multiple peptide groups online. That’s because vendors say these peptides are for research use only or not for human consumption. That industry trade organization has developed an online tool for this task and has suggested questions consumers can ask when choosing a compounding pharmacy.
Chagee Founder Zhang Junjie To Wed Chinese Solar Heiress In December
The fourth prong involves regulatory and law enforcement action against illegal activities, such as counterfeiting and theft. As suggested by many survey respondents, manufacturers and authorized distributors of record can no longer choose to look the other way and ask pharmacies to deal with this issue alone. Legislative action is currently being explored to provide FDA with the expanded authority it needs to better manage drug shortages.
Grey Market Drugs: Profiting From Poorly Managed US Health Care
- This means that a legitimate medicine is imported from a lower-priced country and resold to a higher-priced country.
- They then shove them into a long, gray market pipeline, and the price is marked up at each juncture.
- “Much like with counterfeit versions, these active ingredients come from unregulated, undisclosed sources…
- In return, they leveraged their influence to further empower and protect these enterprises, reinforcing the sway of the black market and the politically connected red mafia.
- The best guess would be somewhere without strict laws on recreational drugs.
Nitazenes have already killed hundreds of people in Europe and left law enforcement and scientists scrambling to detect them in the drug supply and curb their spread. Going online and buying the drugs from unvetted sources that don’t require a prescription “can really put you at harm’s risk,” he says. The list price for GLP-1 drugs runs from around $1,000 to $1,300 per month.
About half (52%) of all respondents reported purchasing one or more pharmaceutical products from gray market vendors during the past 2 years. The vendor insisted there was nothing wrong with selling these medications at hugely inflated prices, knowing full well that patients need these drugs. Providing coupons is a common practice for drug makers to incentivize patients to try their product, instead of a competitor's, especially when it's a new offering in an already-hot and high-priced market. Reports of issues with weight loss drugs containing semaglutide, the active ingredient in Ozempic, or tirzepatide, the active ingredient in Mounjaro, have seen a sharp rise since 2019. A separate but related growing problem is the rise of counterfeit drugs — fake products purporting to be the real thing. Majority of the time, consumers of gray market drugs are unaware of the fact that the purchase they made was from outside of the legitimate supply channel; they are usually unable to ascertain that the proper level of care in terms of handling, temperature and storage was adhered to.
Illegal Websites Crackdown
But the medications aren’t without side effects. So are Melanie’s weight-loss results. Generally, more hormones mimicked means more weight lost.
Your Brand?
Many of the vendors are foreign, requiring payment in cryptocurrencies. "I have patients who have lost up to 125 pounds and feel like they have gotten their life back," Landers says. Landers continues prescribing brand name GLP-1s to patients who can afford them, but some were forced to make tough choices. Many like Liz go "gray" because their base weight or medical history excludes them from insurance coverage.
Normally priced at $25.90 per unit, the drug was offered at $1,200 a unit, a 4,533 percent increase, the report said. That’s according to new research by Premier, a North Carolina-based alliance of 2,500 hospitals and 73,000 other health care sites in the United States. Until comprehensive access to FDA-approved GLP-1 therapies is both universal and affordable, these gray-market solutions will continue to thrive in the space where public health ambition collides with pharmaceutical economics. Whether these compounded formulations—with their added B12, NAD+, or marketing flourish—represent personalized innovation or commercial exploitation depends on your vantage point. The compounded GLP-1 market exists in a precarious balance between access and oversight, necessity and novelty. Compounded drugs, even when legally prepared, are not subject to the same FDA-mandated clinical trials or manufacturing standards as approved drugs.
How Is This Legal (Or Just Not Illegal Enough)?
But in recent months over 50 lawsuits have been filed against Eli Lilly and Novo Nordisk, the drug makers, for alleged side effects such as stomach paralysis. " offered the pharmacies "service that will amaze you." The email concluded, without a hint of irony, "HAVE A JOY FILLED DAY!!!! The major teaching institution still hadn't been able to buy any Doxil and was canceling her rescheduled appointment.Relying on Sub-ContractorsThere are been multiple reasons for drug shortages. They also keep track of supply and demand – not unlike commodity traders – and then take advantage of any changes to make quick profits."I drove home with no treatment. I was in shock," said Eardensohn, 59, a warm and resolutely optimistic mother of two. Ondis Eardensohn discovered a new and growing drug crisis first hand. And that's probably the biggest thing that I've seen, is when patients take these, is that it does nothing.
Gray Market Report
Other patients may not be so lucky, and may have to go to extreme lengths to get their medications. In the meantime, hospitals and clinics will have to bear the burden of higher costs of lifesaving medications. Patients with insurance don’t necessarily see the price increase reflected in their medical bills, though in some cases, hospitals may bill more than the copay set by the insurance provider. The price for another chemotherapy drug, cisplatin, jumped from around $39 to about $195.
Daily Remedy offers the best in healthcare information and healthcare editorial content. Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials. Kumar Ramalingam is a writer focused on the intersection of science, health, and policy, translating complex issues into accessible insights. The FDA has already issued multiple warning letters to compounders over labeling and safety violations related to semaglutide formulations.
Researchers have watched nervously as the resulting gray market of so-called generic semaglutide has ballooned. Ever since the FDA approved the prescription of GLP-1 weight-loss drugs, it's been hard to get hold of the real thing. Particularly worrying, she said, is that most people take nitazenes unwittingly, as contaminants in other drugs. They have been found mixed into heroin and recreational drugs, counterfeit painkillers and antianxiety medication.
FDA Warns Against Dangers Of Gray-market GLP-1 Drugs As Demand Soars In US
It’s the same hustle we saw with compounded semaglutide—just riskier, sketchier, and flying way lower under the radar. There are high level anti-diversion solutions like those provided by Cypheme which ensure that the GPS position of products can be tracked as soon as they are scanned – this provides manufacturers which the much-needed information as to whether or not their products have fallen out of legal distribution channels. Consumer education is a key step in taking the fight to criminal minds that help gray markets thrive; It is important that key pharmaceuticals stakeholders (manufacturers and regulators in particular) take proactive steps to educate consumers on the dangers of using medication purchased outside of the legal channels. A lot of people will go off the drug, and that’s a shame.” When the FDA removes the drugs from the shortage list, 503B compounders must immediately stop selling them.
